Comparison of early childhood vaccination coverage and timeliness between children born to Italian women and those born to foreign women residing in Italy: A multi-centre retrospective cohort study.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
10 04 2019
Historique:
received: 17 12 2018
revised: 05 03 2019
accepted: 13 03 2019
pubmed: 25 3 2019
medline: 15 8 2020
entrez: 24 3 2019
Statut: ppublish

Résumé

Compared to hosting populations, immigrants are usually considered more vulnerable to communicable diseases, many of which are vaccine-preventable. This study aims to estimate vaccination coverage (VC) and timeliness in children born to women from high migratory pressure countries (HMPC) and to evaluate factors affecting differences with children born to Italian women or women from advanced development countries (ITA + ADC). We retrospectively analysed data of children born in 2009-2014 and resident in areas served by three local health units in the cities of Rome (n = 40,284), Turin (n = 49,600), and Treviso (n = 20,080). Data were retrieved through record-linkage of the population, vaccination, and birth registries. We used the Kaplan-Meier method to estimate VCs at different ages for the 3rd dose of vaccine against tetanus and the 1st dose of vaccines against measles and meningococcal group C. Factors affecting differences in VCs by citizenship were evaluated using log-binomial models. In Rome, VCs at 2 years of age were consistently higher in children born to ITA + ADC women than in children born to HMPC women, while differences in VCs by citizenship varied according to antigen and birth-cohort in Turin and Treviso, respectively. Where differences were observed, these were only partially explained by the mother's socio-demographic characteristics, level of utilisation of health-services during pregnancy, and maternal, perinatal, and neonatal outcomes. Finally, we observed a reduction of VCs in recent birth cohorts (2012-14 vs. 2009-11), especially in children born to ITA + ADC women. Differences in VCs by citizenship were not homogeneous and varied according to geographical context, antigen, and birth-cohort. These differences are likely to be also affected by informal barriers (e.g., linguistic and cultural barriers), which should be addressed in implementing strategies to increase vaccine uptake in foreign children. Moreover, our results suggest that effective strategies to promote vaccinations in the autochthonous population are also needed.

Sections du résumé

BACKGROUND
Compared to hosting populations, immigrants are usually considered more vulnerable to communicable diseases, many of which are vaccine-preventable. This study aims to estimate vaccination coverage (VC) and timeliness in children born to women from high migratory pressure countries (HMPC) and to evaluate factors affecting differences with children born to Italian women or women from advanced development countries (ITA + ADC).
METHODS
We retrospectively analysed data of children born in 2009-2014 and resident in areas served by three local health units in the cities of Rome (n = 40,284), Turin (n = 49,600), and Treviso (n = 20,080). Data were retrieved through record-linkage of the population, vaccination, and birth registries. We used the Kaplan-Meier method to estimate VCs at different ages for the 3rd dose of vaccine against tetanus and the 1st dose of vaccines against measles and meningococcal group C. Factors affecting differences in VCs by citizenship were evaluated using log-binomial models.
RESULTS
In Rome, VCs at 2 years of age were consistently higher in children born to ITA + ADC women than in children born to HMPC women, while differences in VCs by citizenship varied according to antigen and birth-cohort in Turin and Treviso, respectively. Where differences were observed, these were only partially explained by the mother's socio-demographic characteristics, level of utilisation of health-services during pregnancy, and maternal, perinatal, and neonatal outcomes. Finally, we observed a reduction of VCs in recent birth cohorts (2012-14 vs. 2009-11), especially in children born to ITA + ADC women.
CONCLUSIONS
Differences in VCs by citizenship were not homogeneous and varied according to geographical context, antigen, and birth-cohort. These differences are likely to be also affected by informal barriers (e.g., linguistic and cultural barriers), which should be addressed in implementing strategies to increase vaccine uptake in foreign children. Moreover, our results suggest that effective strategies to promote vaccinations in the autochthonous population are also needed.

Identifiants

pubmed: 30902479
pii: S0264-410X(19)30345-7
doi: 10.1016/j.vaccine.2019.03.023
pii:
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2179-2187

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Massimo Fabiani (M)

Infectious Diseases Department, Italian National Institute of Health (ISS), Viale Regina Elena 299, 00161 Rome, Italy. Electronic address: massimo.fabiani@iss.it.

Valeria Fano (V)

Local Health Unit 2 (Asl RM2), Via Filippo Meda 35, 00157 Rome, Italy.

Teresa Spadea (T)

Epidemiology Unit, Local Health Unit 3 (Asl TO3), Via Sabaudia 164, 10095 Grugliasco, Turin, Italy.

Cinzia Piovesan (C)

Department of Prevention, Local Health Unit 2 (Ulss 2 Marca Trevigiana), Via S. Ambrogio di Fiera 37, 31100 Treviso, Italy.

Egisto Bianconi (E)

Local Health Unit 2 (Asl RM2), Via Filippo Meda 35, 00157 Rome, Italy.

Raffaella Rusciani (R)

Epidemiology Unit, Local Health Unit 3 (Asl TO3), Via Sabaudia 164, 10095 Grugliasco, Turin, Italy.

Giuseppe Salamina (G)

Local Health Unit (Asl Città di Torino), Via San Secondo 29, 10128 Turin, Italy.

Gregorio Greco (G)

Local Health Unit (Asl Città di Torino), Via San Secondo 29, 10128 Turin, Italy.

Mauro Ramigni (M)

Department of Prevention, Local Health Unit 2 (Ulss 2 Marca Trevigiana), Via S. Ambrogio di Fiera 37, 31100 Treviso, Italy.

Silvia Declich (S)

National Centre for Global Health, Italian National Institute of Health (ISS), Viale Regina Elena 299, 00161 Rome, Italy.

Alessio Petrelli (A)

National Institute for Health, Migration, and Poverty (INMP), Via di S. Gallicano 25, 00153 Rome, Italy.

Patrizio Pezzotti (P)

Infectious Diseases Department, Italian National Institute of Health (ISS), Viale Regina Elena 299, 00161 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH